EQUELL- ivermectin paste
Bimeda, Inc.
----------
FOR ORAL USE IN HORSES ONLY
Removes worms and bots with a single dose.
Contents will treat up to 1320 lb body weight.
Net Weight: 0.225 oz (6.42 g)
Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism. Equell (ivermectin) Paste provides effective control of the following parasites in horses:
Large Strongyles (adults)
Strongylus vulgaris (also early forms in blood vessels)
S. edentatus (also tissue stages)
S. equinus
Triodontophorus spp. including T. brevicauda, T. serratus
Craterostomum acuticaudatum
Small Strongyles (adults, including those resistant to some benzimidazole class compounds)
Coronocyclus spp. including C. coronatus, C. labiatus and C. labratus
Cyathostomum spp. including C. catinatum, C. pateratum
Cylicocyclus spp. including C. insigne, C. leptostomum, C. nassatus, C. brevicapsulatus
Cylicostephanus spp. including C. calicatus, C. goldi, C. longibursatus, C. minutus
Cylicodontophorus spp.
Petrovinema poculatum
Small Strongyles (fourth-stage larvae)
Pinworms (adults and fourth-stage larvae)
Oxyuris equi
Ascarids (adults and third- and fourth-stage larvae)
Parascaris equorum
Hairworms (adults)
Trichostrongylus axei
Large-mouth Stomach Worms (adults)
Habronema muscae
Bots (oral and gastric stages)
Gasterophilus spp. including G. intestinalis and G. nasalis
Lungworms (adults and fourth-stage larvae)
Dictyocaulus arnfieldi
Intestinal Threadworms (adults)
Strongyloides westeri
Summer Sores caused by Habronema and Draschia spp. cutaneous third-stage larvae
Dermatitis caused by Neck Threadworm microfilariae, Onchocerca sp.
This syringe contains sufficient paste to treat one 1320-lb horse at the recommended dose rate of 91 mcg ivermectin per lb (200 mcg/kg) of body weight. Each weight marking on the syringe plunger delivers enough paste to treat 250 lb (114 kg) of body weight.
All horses should be included in a regular parasite control program with particular attention being paid to mares, foals, and yearlings. Foals should be treated initially at 6 to 8 weeks of age, and routine treatment repeated as appropriate. Consult your veterinarian for a control program to meet your specific needs. Equell Paste effectively controls gastrointestinal nematodes and bots of horses. Regular treatment will reduce the chances of verminous arteritis caused by Strongylus vulgaris.
Equell Paste may be used in horses of all ages, including mares at any stage of pregnancy. Stallions may be treated without adversely affecting their fertility.
Do not use in horses intended for human consumption.
Not for use in humans. Keep this and all drugs out of reach of children. Refrain from smoking and eating when handling. Wash hands after use. Avoid contact with eyes.
The Material Safety Data Sheet (MSDS) contains more detailed occupational safety information. To report adverse reactions in users, to obtain more information, or to obtain a MSDS, contact Bimeda, Inc. at 1-888-524-6332.
Equell Paste has been formulated specifically for use in horses only. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.
Ivermectin and excreted ivermectin residues may adversely affect aquatic organisms. Do not contaminate ground or surface water. Dispose of the syringe in an approved landfill or by incineration.
Swelling and itching reactions after treatment with ivermectin paste have occurred in horses carrying heavy infections of neck threadworm (Onchocerca sp. microfilariae). These reactions were most likely the result of microfilariae dying in large numbers. Symptomatic treatment may be advisable. Consult your veterinarian should any such reactions occur. Healing of summer sores involving extensive tissue changes may require other appropriate therapy in conjunction with treatment with Equell Paste. Reinfection, and measures for its prevention, should also be considered. Consult your veterinarian if the condition does not improve.
EQUELL
ivermectin paste |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - Bimeda, Inc. (060492923) |
Registrant - Virbac AH Inc (131568396) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Shandong Qilu King-phar Pharmaceutical Co., Ltd. | 421524323 | api manufacture |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Zhejiang Hisun Pharmaceutical Co., Ltd. | 654211754 | api manufacture |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Virbac Corporation | 829166276 | manufacture |